These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1648507)

  • 1. Activity of soluble factors produced by Epstein-Barr virus-transformed human B lymphocytes on different cell lines.
    Garzelli C; Bazzichi A
    Experientia; 1991 Jul; 47(7):731-4. PubMed ID: 1648507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus-transformed B lymphocytes produce low molecular mass molecules with autocrine growth factor and competence factor activity.
    Garzelli C; Bazzichi A; Dayah AM; Manunta M; Incaprera M; Falcone G
    FEMS Microbiol Lett; 1992 Dec; 100(1-3):449-54. PubMed ID: 1335948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B-cell-derived interleukin 1 (IL-1)-like factor. I. Relationship of production of IL-1-like factor to accessory cell function of Epstein-Barr virus-transformed human B-lymphoblast lines.
    Matsushima K; Kuang YD; Tosato G; Hopkins SJ; Oppenheim JJ
    Cell Immunol; 1985 Sep; 94(2):406-17. PubMed ID: 2992808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of B cell responsiveness to growth factors by Epstein-Barr virus conversion: comparison of endogenous factors and interleukin-1.
    Blazar BA; Murphy AM
    Clin Exp Immunol; 1990 Apr; 80(1):62-8. PubMed ID: 2157568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphotoxin is an autocrine growth factor for Epstein-Barr virus-infected B cell lines.
    Estrov Z; Kurzrock R; Pocsik E; Pathak S; Kantarjian HM; Zipf TF; Harris D; Talpaz M; Aggarwal BB
    J Exp Med; 1993 Mar; 177(3):763-74. PubMed ID: 8382256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr Virus (EBV) Latent Protein EBNA3A Directly Targets and Silences the
    Bazot Q; Paschos K; Allday MJ
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29367247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Manipulation of the toll-like receptor 7 signaling pathway by Epstein-Barr virus.
    Martin HJ; Lee JM; Walls D; Hayward SD
    J Virol; 2007 Sep; 81(18):9748-58. PubMed ID: 17609264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphotoxin acts as an autocrine growth factor for Epstein-Barr virus-transformed B cells and differentiated Burkitt lymphoma cell lines.
    Gibbons DL; Rowe M; Cope AP; Feldmann M; Brennan FM
    Eur J Immunol; 1994 Aug; 24(8):1879-85. PubMed ID: 8056047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD40 ligand is a critical effector of Epstein-Barr virus in host cell survival and transformation.
    Imadome K; Shirakata M; Shimizu N; Nonoyama S; Yamanashi Y
    Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7836-40. PubMed ID: 12805559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autocrine models of B-lymphocyte growth. I. Role of cell contact and soluble factors in T-independent B-cell responses.
    Gordon J; Guy G; Walker L
    Immunology; 1985 Oct; 56(2):329-35. PubMed ID: 2997026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the Epstein-Barr virus (EBV)-encoded membrane antigen (LMP) increases the stimulatory capacity of EBV-negative B lymphoma lines in allogeneic mixed lymphocyte cultures.
    Cuomo L; Trivedi P; Wang F; Winberg G; Klein G; Masucci MG
    Eur J Immunol; 1990 Oct; 20(10):2293-9. PubMed ID: 2173662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus-containing B-cell line produces an interleukin 1 that it uses as a growth factor.
    Wakasugi H; Rimsky L; Mahe Y; Kamel AM; Fradelizi D; Tursz T; Bertoglio J
    Proc Natl Acad Sci U S A; 1987 Feb; 84(3):804-8. PubMed ID: 3027706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cell-derived growth factors and cytokines on the clonal outgrowth of EBV-infected B cells and established lymphoblastoid cell lines.
    Ifversen P; Zhang XM; Ohlin M; Zeuthen J; Borrebaeck CA
    Hum Antibodies Hybridomas; 1993 Jul; 4(3):115-23. PubMed ID: 8395232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus transformation induces B lymphocytes to produce human interleukin 10.
    Burdin N; Péronne C; Banchereau J; Rousset F
    J Exp Med; 1993 Feb; 177(2):295-304. PubMed ID: 8381152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein Barr virus binding induces internalization of the C3d receptor: a novel immunotoxin delivery system.
    Tedder TF; Goldmacher VS; Lambert JM; Schlossman SF
    J Immunol; 1986 Aug; 137(4):1387-91. PubMed ID: 3016095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival.
    Tempera I; De Leo A; Kossenkov AV; Cesaroni M; Song H; Dawany N; Showe L; Lu F; Wikramasinghe P; Lieberman PM
    J Virol; 2016 Jan; 90(1):345-55. PubMed ID: 26468528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic effector cells specific for B Cell lines transformed by Epstein-Barr virus are present in patients with infectious mononucleosis.
    Svedmyr E; Jondal M
    Proc Natl Acad Sci U S A; 1975 Apr; 72(4):1622-6. PubMed ID: 165518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infection of EBV-genome-negative and -positive human lymphoblastoid cell lines with biologically different preparations of EBV.
    Klein G; Sugden B; Leibold W; Menezes J
    Intervirology; 1974; 3(4):232-44. PubMed ID: 4376804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of monoclonal antibody to the Epstein Barr virus (EBV)/CR2 receptor induces activation and differentiation of human B lymphocytes.
    Nemerow GR; McNaughton ME; Cooper NR
    J Immunol; 1985 Nov; 135(5):3068-73. PubMed ID: 2995485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complex forms of mitochondrial DNA in human B cells transformed by Epstein-Barr virus (EBV).
    Christiansen G; Christiansen C; Zeuthen J
    J Cancer Res Clin Oncol; 1983; 105(1):13-9. PubMed ID: 6300133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.